Literature DB >> 20299805

Time of birth, residential solar radiation and age at onset of multiple sclerosis.

Tzu-Yun McDowell1, Sania Amr, Patricia Langenberg, Walter Royal, Christopher Bever, William J Culpepper, Douglas D Bradham.   

Abstract

UNLABELLED: BACKGROUNDS/AIM: Gestational and early life events have been suggested to contribute to multiple sclerosis (MS) susceptibility. We assessed the effects of time and place of birth on the age at onset of MS symptoms.
METHODS: We selected a national cohort of 967 veterans from the Multiple Sclerosis Surveillance Registry for whom month and season (time) of birth, and birthplace (city and state) were available. Multiple linear regression analyses were used to examine the association between time of birth, birthplace latitude and solar radiation, and the age at onset of MS symptoms among the study sample.
RESULTS: Patients with a relapsing form of the disease (R-MS), who were born in winter and whose birthplace was in low solar radiation areas, had disease symptom onset on average 2.8 years earlier than those born in seasons other than winter and in medium- and high-solar radiation areas (p = 0.02).
CONCLUSIONS: These results suggest that exposure early in life to geographical and seasonal factors, possibly related to the protective effect of sunlight, and thus vitamin D, is associated with a delay in MS symptom onset. Other larger studies are required to examine the period-specific (from conception to adulthood) environmental factors that are associated with MS susceptibility. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20299805      PMCID: PMC2883840          DOI: 10.1159/000297749

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  32 in total

1.  The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.

Authors:  S R Hammond; D R English; J G McLeod
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

Review 2.  Increasing response rates to postal questionnaires: systematic review.

Authors:  Phil Edwards; Ian Roberts; Mike Clarke; Carolyn DiGuiseppi; Sarah Pratap; Reinhard Wentz; Irene Kwan
Journal:  BMJ       Date:  2002-05-18

3.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Lynn I Levin; Kassandra L Munger; Mark V Rubertone; Charles A Peck; Evelyne T Lennette; Donna Spiegelman; Alberto Ascherio
Journal:  JAMA       Date:  2003-03-26       Impact factor: 56.272

4.  Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.

Authors:  G Dean
Journal:  Br Med J       Date:  1967-06-17

5.  Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation.

Authors:  I A van der Mei; A L Ponsonby; L Blizzard; T Dwyer
Journal:  Neuroepidemiology       Date:  2001-08       Impact factor: 3.282

Review 6.  Vitamin D: a natural inhibitor of multiple sclerosis.

Authors:  C E Hayes
Journal:  Proc Nutr Soc       Date:  2000-11       Impact factor: 6.297

7.  Parent-of-origin effect in multiple sclerosis: observations in half-siblings.

Authors:  G C Ebers; A D Sadovnick; D A Dyment; I M L Yee; C J Willer; Neil Risch
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

Review 8.  Living with the past: evolution, development, and patterns of disease.

Authors:  Peter D Gluckman; Mark A Hanson
Journal:  Science       Date:  2004-09-17       Impact factor: 47.728

9.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study.

Authors:  I A F van der Mei; A-L Ponsonby; T Dwyer; L Blizzard; R Simmons; B V Taylor; H Butzkueven; T Kilpatrick
Journal:  BMJ       Date:  2003-08-09

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more
  8 in total

1.  Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations.

Authors:  Luis Hernandez; Malinda O'Donnell; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

2.  Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis.

Authors:  Jacob D Reynolds; Laure K Case; Dimitry N Krementsov; Abbas Raza; Rose Bartiss; Cory Teuscher
Journal:  FASEB J       Date:  2017-03-14       Impact factor: 5.191

Review 3.  Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.

Authors:  Hong-Liang Zhang; Jiang Wu
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

Review 4.  Influence of photoperiod on hormones, behavior, and immune function.

Authors:  James C Walton; Zachary M Weil; Randy J Nelson
Journal:  Front Neuroendocrinol       Date:  2010-12-13       Impact factor: 8.606

5.  Long-term effects of latitude, ambient temperature, and ultraviolet radiation on the incidence of multiple sclerosis in two cohorts of US women.

Authors:  Thao Lam; Trang VoPham; Kassandra L Munger; Francine Laden; Jaime E Hart
Journal:  Environ Epidemiol       Date:  2020-07-06

6.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 7.  Consideration for gene-environment interactions as novel determinants of exfoliation syndrome.

Authors:  Louis R Pasquale; Jae H Kang; Janey L Wiggs
Journal:  Int Ophthalmol Clin       Date:  2014

8.  Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis.

Authors:  Zahra Tolou-Ghamari; Vahid Shygannejad; Fereshteh Ashtari; Ahmad Chitsaz; Abbas Ali Palizban
Journal:  Adv Biomed Res       Date:  2015-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.